Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements

P. De Lorenzo; A. V. Moorman; R. Pieters; Z. E. Dreyer; N. A. Heerema; A. J. Carroll; S. P. Hunger; R. Harvey; C. L. Willman; M. Devidas; M. G. Valsecchi; C. J. Harrison

doi:10.1038/leu.2013.280

Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements

P. De Lorenzo, A. V. Moorman, R. Pieters, Z. E. Dreyer, N. A. Heerema, A. J. Carroll, S. P. Hunger, R. Harvey, C. L. Willman, M. Devidas, M. G. Valsecchi, C. J. Harrison

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

22 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	428-430
Aantal pagina's	3
Tijdschrift	Leukemia
Volume	28
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1038/leu.2013.280
Status	Gepubliceerd - feb. 2014
Extern gepubliceerd	Ja

Toegang tot document

10.1038/leu.2013.280

Citeer dit

@article{b06b194e10cf449c87911fa5d304f9dd,

title = "Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements",

author = "{De Lorenzo}, P. and Moorman, {A. V.} and R. Pieters and Dreyer, {Z. E.} and Heerema, {N. A.} and Carroll, {A. J.} and Hunger, {S. P.} and R. Harvey and Willman, {C. L.} and M. Devidas and Valsecchi, {M. G.} and Harrison, {C. J.}",

note = "Funding Information: This work was supported in part by grants from the NCI to the Children{\textquoteright}s Oncology Group including U10 CA98543 (COG Chair{\textquoteright}s grant), U10 CA98413 (COG Statistics & Data Center) and U24 CA114766 (COG Specimen Banking). CLW and RH were additionally supported by a Leukemia and Lymphoma Specialized Center of Research Grant in Infant Leukemia (17 372). SPH is the Ergen Family Chair in Pediatric Cancer. The study was also partially supported by Leukaemia Lymphoma Research, UK (to CJH and AVM) and Associazione Italiana Ricerca sul Cancro: Investigator Grant Code 5017 (to MGV). The Interfant99 international study operating center is partially supported by Fondazione Tettamanti and Comitato ML Verga (to MGV and PDL). Funding Information: This study was supported in part by a Grant-in-Aid from the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by grants for Third-Term Comprehensive Control Research for Cancer and for Research on Human Genome Tailor-made from the Ministry of Health, Labor and Welfare of Japan.",

year = "2014",

month = feb,

doi = "10.1038/leu.2013.280",

language = "English",

volume = "28",

pages = "428--430",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements

AU - De Lorenzo, P.

AU - Moorman, A. V.

AU - Pieters, R.

AU - Dreyer, Z. E.

AU - Heerema, N. A.

AU - Carroll, A. J.

AU - Hunger, S. P.

AU - Harvey, R.

AU - Willman, C. L.

AU - Devidas, M.

AU - Valsecchi, M. G.

AU - Harrison, C. J.

N1 - Funding Information: This work was supported in part by grants from the NCI to the Children’s Oncology Group including U10 CA98543 (COG Chair’s grant), U10 CA98413 (COG Statistics & Data Center) and U24 CA114766 (COG Specimen Banking). CLW and RH were additionally supported by a Leukemia and Lymphoma Specialized Center of Research Grant in Infant Leukemia (17 372). SPH is the Ergen Family Chair in Pediatric Cancer. The study was also partially supported by Leukaemia Lymphoma Research, UK (to CJH and AVM) and Associazione Italiana Ricerca sul Cancro: Investigator Grant Code 5017 (to MGV). The Interfant99 international study operating center is partially supported by Fondazione Tettamanti and Comitato ML Verga (to MGV and PDL). Funding Information: This study was supported in part by a Grant-in-Aid from the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by grants for Third-Term Comprehensive Control Research for Cancer and for Research on Human Genome Tailor-made from the Ministry of Health, Labor and Welfare of Japan.

PY - 2014/2

Y1 - 2014/2

UR - http://www.scopus.com/inward/record.url?scp=84893740353&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.280

DO - 10.1038/leu.2013.280

M3 - Letter

C2 - 24072099

AN - SCOPUS:84893740353

SN - 0887-6924

VL - 28

SP - 428

EP - 430

JO - Leukemia

JF - Leukemia

IS - 2

ER -